Todd Zavodnick
Chief Executive Officer (CEO)
About
Seasoned biopharmaceutical leader with over 25 years of global commercial, operational, and executive experience spanning ophthalmology, dermatology, aesthetics, and specialty medicine. Previously CEO of Dermavant Sciences (2018-2024), where he led clinical-stage biotech through multiple late-stage programs, product launches, and commercial scale-up. Former President, International & Chief Commercial Officer at Revance Therapeutics; President, International at ZELTIQ (prior to its $2.4 billion acquisition by Allergan); senior leadership roles at Galderma (U.S. & Global) and over a decade at Alcon. Holds Bachelor of Science in Pharmacy from Rutgers University and M.B.A. from University of Texas at Dallas. Serves on Board of Directors for Children's Skin Disease Foundation.
Contact Details
Want products like this in your inbox every morning?
Five products. Every morning. Written by someone who actually cares whether they're good or not. Free forever, unsubscribe whenever.